2026 Price of AlectinibIn 2026, the price of alectinib varies by region, medical insurance policy, and purchasing channel.The Lao Da Xiong version of ···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 107
FDA Approval AnnouncementDecember 11, 2015 -- The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced ···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 112
FDA Approval AnnouncementSouth San Francisco, CA -- November 6, 2017 - Genentech, a member of the Roche Group, today announced that the U.S. Food and ···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 109
FDA Approval AnnouncementSouth San Francisco, CA -- April 18, 2024 -- Genentech, a member of the Roche Group, announced today that the U.S. Food and D···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 119
Adverse Reactions of AlectinibAlectinib’s adverse reactions are based on clinical trial and post-marketing observations. Incidence rates are for refer···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 107
Main EfficacyAlectinib is indicated as monotherapy for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or me···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 110
Apalutamide is to treatprostate cancerthat has spread to other parts of the body (metastatic) and still responds to a medical or surgical treatment th···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 126
Take the missed dose on the same day you remember it. Take your next dose at the regular time and stay on your once-daily schedule. Do not take two do···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 123
Apalutamide can cause seizures. Avoid activities that could be dangerous if you have an unexpected seizure.【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 120
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 120
Apalutamide is an oral anti-androgen medication, mainly used to treat non-metastatic or metastatic castration-resistant prostate cancer. It delays tum···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 119
FDA Approval AnnouncementFebruary 14, 2018 -- The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 114
FDA Approval AnnouncementHORSHAM, Pa., Sept. 17, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today th···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 112
KRAS mutations have been considered a major challenge in cancer research, remaining difficult to overcome for many years. The introduction of Sotorasi···【Read More】
Update: 2026-03-04Source: Haiou HealthViews: 113
Sotorasib is a KRASG12C inhibitor developed by Amgen. It received accelerated approval from the U.S. Food and Drug Administration (FDA) in May 2021.I.···【Read More】
Update: 2026-03-03Source: Haiou HealthViews: 113
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



